Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress - Eledon Pharma (NASDAQ:ELDN) : vimarsana.com

Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress - Eledon Pharma (NASDAQ:ELDN)

Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress - Eledon Pharma (NASDAQ:ELDN)

benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Berlin , Germany , United States , Massachusetts , Philadelphia , Pennsylvania , University Of California San Francisco , California , Irvine , American , Allan Kirk , Jay Fishman , Steve Perrin , Klemens Budde , Roslyn Mannon , Stephen Jasper , Diane Cibrik , Flavio Vincenti , University Of Nebraska Medical Center , Eledon Pharmaceuticals , American Transplant Congress , Twitter , University Of Kansas Health System , Gilmartin Group , Berry Company Public Relations , Duke University School Of Medicine , Linkedin , Eledon Pharmaceuticals Inc , Ongoing Phase , Antibody Tegoprubart , Chief Scientific Officer , Solid Organ Transplantation , California San Francisco , Kansas Health System , Duke University School , Massachusetts General Hospital , Nebraska Medical ,